|
End-of-day quote
Shanghai S.E.
12/11/2026
|
5-day change | 1st Jan Change | ||
| 3.210 CNY | +0.31% |
|
-1.83% | -19.35% |
| Market Cap | 2.52B 377M 341M 315M 285M 538M 35.46B 554M 3.78B 1.5B 18.96B 1.42B 1.39B 60.34B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74B 410M 370M 342M 310M 584M 38.51B 602M 4.1B 1.63B 20.59B 1.54B 1.5B 65.54B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.31% | ||
| 1 week | -1.83% | ||
| Current month | +0.63% | ||
| 1 month | -9.32% | ||
| 3 months | -17.27% | ||
| 6 months | -21.32% | ||
| Current year | -19.35% |
| 1 week | 3.15 |  | 3.26 |
| 1 month | 3.08 | | 3.59 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 12/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 05/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 16/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 21/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 20/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 02/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.31% | -1.83% | -28.19% | -44.94% | 377M | |
| -0.70% | +4.58% | +40.23% | +138.79% | 1,271B | |
| +1.11% | +4.11% | +45.85% | +92.54% | 683B | |
| -0.18% | +2.15% | +26.25% | +112.46% | 520B | |
| +1.14% | +3.78% | +39.98% | +71.70% | 389B | |
| -0.16% | +0.01% | +60.69% | +44.94% | 362B | |
| +1.11% | +0.07% | +28.19% | +60.05% | 304B | |
| +0.24% | -0.80% | +3.05% | +38.06% | 286B | |
| -0.22% | +1.47% | +38.89% | +74.73% | 253B | |
| -1.05% | +0.23% | +36.10% | +121.22% | 208B | |
| Average | +0.16% | +1.59% | +29.10% | +70.95% | 428B | |
| Weighted average by Cap. | +0.07% | +2.67% | +37.51% | +97.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 326M 294M 272M 246M 464M 30.62B 478M 3.26B 1.3B 16.37B 1.22B 1.2B 52.1B | 1.86B 279M 252M 233M 211M 398M 26.23B 410M 2.8B 1.11B 14.02B 1.05B 1.03B 44.64B |
| Net income | -317M -47.52M -42.97M -39.66M -35.9M -67.75M -4.47B -69.78M -476M -189M -2.39B -178M -175M -7.6B | -330M -49.37M -44.64M -41.21M -37.3M -70.39M -4.64B -72.5M -495M -197M -2.48B -185M -181M -7.9B |
| Net Debt | 411M 61.55M 55.66M 51.38M 46.5M 87.75M 5.79B 90.38M 617M 245M 3.09B 231M 226M 9.85B | 217M 32.52M 29.41M 27.15M 24.57M 46.37M 3.06B 47.76M 326M 129M 1.63B 122M 119M 5.2B |
Employees
4,832
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | CN¥3.210 | +0.31% | 14,869,938 |
| 11/11/26 | CN¥3.200 | +0.31% | 12,220,400 |
| 10/11/26 | CN¥3.190 | +0.63% | 11,403,317 |
| 09/11/26 | CN¥3.170 | -0.94% | 15,152,230 |
| 06/11/26 | CN¥3.200 | -2.14% | 15,488,000 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
